Insys Therapeutics, Inc.
SEC CIK 1516479 · INSY · last insider filing 2019-06-06
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Long Andrew G | Director · Chief Financial Officer | filed 2017 - 2019 |
| Lapalme Pierre | Director | filed 2013 - 2019 |
| Meyer Steven J | Director | filed 2013 - 2019 |
| Mahboob Vaseem | Director | filed 2018 - 2019 |
| Motahari Saeed | Director · President & CEO | filed 2017 - 2019 |
| Vishnoi Rohit | Director | filed 2017 - 2019 |
| Bohlen Elizabeth | Director | filed 2018 - 2019 |
| Vanhove Geertrui | Director | filed 2019 - 2019 |
| Tambi Brian | Director | filed 2013 - 2018 |
| Kapoor John N | Director | filed 2013 - 2018 |
| John N Kapoor Trust Dated September 20 1989 | Director · President & CEO | filed 2013 - 2018 |
| Fourteau Patrick | Director | filed 2013 - 2017 |
| Stanley Theodore H | Director | filed 2013 - 2017 |
| Babich Michael L | Director · President and CEO | filed 2013 - 2015 |
| Meyer Steven | Director | filed 2013 - 2013 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Housley Andrece | Chief Financial Officer | filed 2019 - 2019 |
| Nance Mark E | Chief Legal Officer & Gen Cnsl | filed 2018 - 2019 |
| Del Fosse Franc | General Counsel | filed 2014 - 2017 |
| Baker Darryl S | Chief Financial Officer | filed 2013 - 2017 |
| Vetticaden Santosh | Interim CEO and CMO | filed 2017 - 2017 |
| Brennan Daniel | Exec VP & Chf Operations Off. | filed 2015 - 2016 |
| Homrich Christopher F | Sr. VP Operations | filed 2014 - 2014 |
| Dillaha Larry | Chief Medical Officer | filed 2013 - 2014 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.